Table 1. Study subjects Subject . CD4... | American Society of Hematology

Table 1.

Study subjects

Subject	CD4 count, cells/μL	Viral load, copies/mL	Duration of treatment, y	Duration of infection, y
1	693	3 996	—	15
2	636	1 800	—	> 12
3	327	125	—	> 12
4	875	10 152	—	> 3
5	1311	12 226	—	> 15
6	648	4 846	—	8
7	750	4 800	—	> 6
8	255	22 950	—	> 3
9	577	24 135	—	> 2
10	335	110 950	—	< 10
11	742	170 044	—	< 1
12	369	6 401	—	< 2
13	706	13 930	—	< 1
14	1130	49 980	—	< 1
15	64	65 000	—	> 1
16	181	71 712	—	> 6
17	227	446 000	—	< 4
18	824	16 584	—	< 2
19	718	44 389	—	< 4
20	705	832	11	> 11
21	190	1 005	6	> 6
22	636	2 546	5	> 5
23	588	5 936	8	> 8
24	307	13 838	4	> 4
25	869	18 049	5	> 5
26	723	18 393	3	> 3
27	462	18 480	10	> 10
28	131	47 760	5	> 5
29	412	84 093	4	> 4
30	403	120	2	> 2
31	HIV−	HIV−	HIV−	HIV−

Subject	CD4 count, cells/μL	Viral load, copies/mL	Duration of treatment, y	Duration of infection, y
1	693	3 996	—	15
2	636	1 800	—	> 12
3	327	125	—	> 12
4	875	10 152	—	> 3
5	1311	12 226	—	> 15
6	648	4 846	—	8
7	750	4 800	—	> 6
8	255	22 950	—	> 3
9	577	24 135	—	> 2
10	335	110 950	—	< 10
11	742	170 044	—	< 1
12	369	6 401	—	< 2
13	706	13 930	—	< 1
14	1130	49 980	—	< 1
15	64	65 000	—	> 1
16	181	71 712	—	> 6
17	227	446 000	—	< 4
18	824	16 584	—	< 2
19	718	44 389	—	< 4
20	705	832	11	> 11
21	190	1 005	6	> 6
22	636	2 546	5	> 5
23	588	5 936	8	> 8
24	307	13 838	4	> 4
25	869	18 049	5	> 5
26	723	18 393	3	> 3
27	462	18 480	10	> 10
28	131	47 760	5	> 5
29	412	84 093	4	> 4
30	403	120	2	> 2
31	HIV−	HIV−	HIV−	HIV−

Clinical information for subject cohort. — indicates treatment naive.